Last edition
News about "Servier Pharmaceuticals "
Atavistik Bio Appoints Dr. Susan Pandya as Chief Medical Officer
As CMO, Dr. Susan Pandya will lead all clinical development strategy and execution for Atavistik Bio, including the ongoing Phase 1 clinical trial of its lead programme, ATV-1601.
Servier Pharmaceuticals | 15/09/2025 | By Dineshwori | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members